Institutional Ownership
Regentis Biomaterials Ltd
CUSIP M8211G108ORDINARY SHARESRGNTQ1 2026
13D / 13G Filings
1
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
23.2%
Max % of class reported
Institutional Holders
3
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
1 filings · latest Feb 17, 2026
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Feb 17, 2026 | Dr. Ehud Geller | 13G | 23.2% | 1.33M | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Aigh Capital Management LLC | 300.0K | $916.5K |
| 2 | Rosalind Advisors, Inc. | 251.5K | $768.4K |
| 3 | Ubs Group AG | 334 | $1.0K |